packagePabinafuspAlfa

pabinafusp alfa

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Pabinafusp alfa is an investigational enzyme replacement therapy being studied for Hunter syndrome (mucopolysaccharidosis type II). It is not yet approved; it remains in clinical development, mainly in Japan.

Summary written by glm-5.3-flash from Wikidata Q107327238 and the WHO ATC classification; not checked by a person.

name:pabinafusp alfa
ATC codes:A16AB27
DrugBank:DB15633
Wikidata:Q107327238

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown